KR950031082A - 우르소데옥시콜린산의 신규한 유도체와 이를 포함하는 제약학적 성분물 - Google Patents
우르소데옥시콜린산의 신규한 유도체와 이를 포함하는 제약학적 성분물 Download PDFInfo
- Publication number
- KR950031082A KR950031082A KR1019940013676A KR19940013676A KR950031082A KR 950031082 A KR950031082 A KR 950031082A KR 1019940013676 A KR1019940013676 A KR 1019940013676A KR 19940013676 A KR19940013676 A KR 19940013676A KR 950031082 A KR950031082 A KR 950031082A
- Authority
- KR
- South Korea
- Prior art keywords
- same
- pharmaceutical ingredients
- ursodeoxycholic acid
- novel derivatives
- ursoamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
우르소아미드 티오메틸-α-아미노부틸산은 간질환과 간경변증의 치료에 유용하다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (2)
- 간질환, 만성 간질환과 간경변증 치료에 유용한 제약학적 성분물 제조에 있어서, 하기와 같은 구조의 우르소아미드 티오메틸-α-아미노부틸산의 용도.
- 하기와 같은 구조의 우르소아미드 티오메틸-α-아미노부틸산이 활성성분이 되고, 통상적인 부형제와 수용체를 포함하는 것을 특징으로 하는 구강용형의 제약학적 성분들.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH01488/94-8 | 1994-05-13 | ||
| CH01488/94A CH688677A5 (it) | 1994-05-13 | 1994-05-13 | Derivato dell'acido ursodesossicolico e sue composizioni farmaceutiche. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR950031082A true KR950031082A (ko) | 1995-12-18 |
Family
ID=4211637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019940013676A KR950031082A (ko) | 1994-05-13 | 1994-06-17 | 우르소데옥시콜린산의 신규한 유도체와 이를 포함하는 제약학적 성분물 |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR950031082A (ko) |
| CH (1) | CH688677A5 (ko) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100802013B1 (ko) * | 2006-08-10 | 2008-02-12 | (주)유케이케미팜 | 페길화된 우루소데옥시 콜린산 유도체와 그의 제조방법 |
-
1994
- 1994-05-13 CH CH01488/94A patent/CH688677A5/it not_active IP Right Cessation
- 1994-06-17 KR KR1019940013676A patent/KR950031082A/ko not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100802013B1 (ko) * | 2006-08-10 | 2008-02-12 | (주)유케이케미팜 | 페길화된 우루소데옥시 콜린산 유도체와 그의 제조방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| CH688677A5 (it) | 1998-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2003119460A (ru) | Применение пэг-интерферона-а(пэг-inf-а) и рибавирина для лечения хронического гепатита с | |
| KR950031069A (ko) | 골손실의 억제 및 혈청 콜레스테롤의 강하 방법 | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| BR0108435A (pt) | Formulação e uso de entecavir de baixa dose | |
| DE3689252D1 (de) | Arzneimittel gegen chronische Graft-versus-Host-Krankheiten sowie gegen Autoimmunerkrankungen, insbesondere systemischen Lupus erythematodes. | |
| ES2185179T3 (es) | Preparacion de composiciones farmaceuticas. | |
| IT1246188B (it) | Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. | |
| ATE270544T1 (de) | Halbfeste arzneizubereitung enthaltend isotretinoin | |
| FR2712807B1 (fr) | Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale . | |
| DE3669106D1 (de) | Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. | |
| EE04493B1 (et) | Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks | |
| KR970025615A (ko) | 암 전이 억제제 | |
| KR940018087A (ko) | 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드 | |
| FR2674754B1 (fr) | Composition medicamenteuse micronisee. | |
| KR950016747A (ko) | 여성의 임신 억제방법 | |
| KR970061246A (ko) | 테스토스테론을 증가시키기 위한 약학 조성물 | |
| KR890001564A (ko) | 약학적 투여 단위 | |
| KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
| IT9019112A1 (it) | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina | |
| SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
| KR950031082A (ko) | 우르소데옥시콜린산의 신규한 유도체와 이를 포함하는 제약학적 성분물 | |
| DK0559682T3 (da) | Topisk præparat | |
| BR0212744A (pt) | Formulações de cisplatina de toxicidade reduzida e métodos para uso das mesmas | |
| KR880004810A (ko) | 소화성 궤양 치료제 | |
| KR910004186A (ko) | 제약학적 배합물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |